Candida albicans endocarditis associated with a contaminated aortic valve allograft: Implications for regulation of allograft processing

Clinical Infectious Diseases

Volumn 27, Issue 4, 1998, Pages 688-691

  Kuehnert, Matthew J ^a   Clark, Elizabeth ^b   Lockhart, Shawn R ^b   Soll, David R ^b   Chia, John ^b   Jarvis, William R ^b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTICLE; BACTERIUM ISOLATE; CANDIDA ALBICANS; CASE REPORT; CONTAMINATION; DISINFECTION; ENDOCARDITIS; FUNGEMIA; HEART TRANSPLANTATION; HUMAN; MALE; PRIORITY JOURNAL;

EID: 2442759436     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514944     Document Type: Article

References (16)

1. Ross DN. Homograft replacement of the aortic valve. Lancet 1962; 2:487.
2. Gall K, Smith S, Willmette C, Wong M, O'Brien M. Allograft heart valve sterilization: a six-year in-depth analysis of a twenty-five-year experience with low dose antibiotics. J Thorac Cardiovasc Surg 1995; 110:680-7.
3. McGiffin DC, Galbraith AJ, McLachlan GJ, et al. Aortic valve infection: risk factors for death and recurrent endocarditis after aortic valve replacement. J Thorac Cardiovasc Surg 1992; 104:511-20.
4. National Committee for Clinical Laboratory Standards (NCCLS). Reference method for broth dilution antifungal susceptibility testing of yeasts: proposed standard M27-P. Villanova, Pennsylvania: NCCLS, 1992.
5. Anderson J, Srikantha T, Miyasaki SH, et al. Characterization and partial nucleotide sequence of the DNA fingerprinting probe Ca3 of Candida albicans. J Clin Microbiol 1993; 31:1472-80.
6. Schmid J, Voss E, Soll DR. Computer-assisted methods for assessing strain relatedness in Candida albicans by fingerprinting with the moderately repetitive sequence Ca3. J Clin Microbiol 1990; 28:1236-43.
7. Lockhart S, Fritch JJ, Meier AS, et al. Colonizing populations of Candida albicans are clonal in origin but undergo microevolution through C1 fragment reorganization as demonstrated by DNA fingerprinting and Cl segmenting. J Clin Microbiol 1995; 33:1501-9.
8. Wain WH, Pearce HM, Riddell RW, Ross DN. A re-evaluation of antibiotic sterilisation of heart valve aliografts. Thorax 1977; 32:740-2.
9. McLeod R, Remington JS. Fungal endocarditis. In: Rahimtoola SH, ed. Infective endocarditis. New York: Grune & Stratum, 1978:212-24.
10. Wain WH. Antifungal treatment of allograft tissue for cardiac surgery. Sabouraudia 1981; 19:199-204.
11. Wain WH, Ahmed M, Thompson R, Yacoub M. The role of chemotherapy in the management of fungal endocarditis following homograft valve replacement. Postgrad Med J 1979; 55:629-31.
12. O'Brien MF, Stafford EG, Gardner MA, et al. Allograft aortic valve replacement: long-term follow-up. Ann Thorac Surg 1995; 60:565-70.
13. Barratt-Boyes BG, Roche AHG. A review of aortic valve homografts over a six and one-half year period. Ann Surg 1969; 170:483-92.
14. Stinson EB, Angell WW, Iben AB, Shumway NE. Aortic valve replacement with the fresh valve homograft. Am J Surg 1968; 116:204-9.
15. American Association of Tissue Banks (AATB). Standards for cardiovascular tissue. In: Linden JV, ed. Standards for tissue banking. McLean, Virginia: AATB, 1996:97-108.
16. U.S. Food and Drug Administration. Proposed approach to regulation of cellular and tissue-based products: availability and public meeting. Federal Register 1997; 62:9721.